|
2016 Journal Article Evaluation of novel metrics of symptom relief in acute heart failure: the worst symptom scoreAbouezzeddine, Omar F., Wong, Yee Weng, Mentz, Robert J., Raza, Sadi S., Nativi-Nicolau, Jose, Kociol, Robb D., McNulty, Steven E., Anstrom, Kevin J., Hernandez, Adrian F. and Redfield, Margaret M. (2016). Evaluation of novel metrics of symptom relief in acute heart failure: the worst symptom score. Journal of Cardiac Failure, 22 (11), 853-858. doi: 10.1016/j.cardfail.2015.12.015 |
|
2016 Journal Article Point-of-care INR compared to laboratory INR in patients supported with a continuous flow left ventricular assist deviceMarkham, R., Challa, A., Kyranis, S., Bancroft, J., Javorsky, G., Wong, Y.W. and Platts, D. (2016). Point-of-care INR compared to laboratory INR in patients supported with a continuous flow left ventricular assist device. International Journal of Cardiology, 221, 652-653. doi: 10.1016/j.ijcard.2016.07.010 |
|
2016 Journal Article Nesiritide in patients hospitalized for acute heart failure: does timing matter? Implication for future acute heart failure trialsWong, Yee Weng, Mentz, Robert J., Felker, G. Michael, Ezekowitz, Justin, Pieper, Karen, Heizer, Gretchen, Hasselblad, Vic, Metra, Marco, O'Connor, Christopher M., Armstrong, Paul W., Starling, Randall C. and Hernandez, Adrian F. (2016). Nesiritide in patients hospitalized for acute heart failure: does timing matter? Implication for future acute heart failure trials. European Journal of Heart Failure, 18 (6), 684-692. doi: 10.1002/ejhf.487 |
|
2013 Journal Article Early intravenous heart failure therapy and outcomes among older patients hospitalized for acute decompensated heart failure: findings from the Acute Decompensated Heart Failure Registry Emergency Module (ADHERE-EM)Wong, Yee Weng, Fonarow, Gregg C., Mi, Xiaojuan, Peacock, W. Frank, Mills, Roger M., Curtis, Lesley H., Qualls, Laura G. and Hernandez, Adrian F. (2013). Early intravenous heart failure therapy and outcomes among older patients hospitalized for acute decompensated heart failure: findings from the Acute Decompensated Heart Failure Registry Emergency Module (ADHERE-EM). American Heart Journal, 166 (2), 349-356. doi: 10.1016/j.ahj.2013.05.014 |
|
2013 Journal Article Predictors of incident heart failure hospitalizations among patients with impaired glucose tolerance: insight from the nateglinide and valsartan in impaired glucose tolerance outcomes research studyWong, Yee Weng, Thomas, Laine, Sun, Jie-Lena, McMurray, John J. V., Krum, Henry, Hernandez, Adrian F., Rutten, Guy E. H. M., Leiter, Lawrence A., Standl, Eberhard, Haffner, Steven M., Mazzone, Theodore, Martinez, Felipe A., Tognoni, Gianni, Giles, Thomas and Califf, Robert M. (2013). Predictors of incident heart failure hospitalizations among patients with impaired glucose tolerance: insight from the nateglinide and valsartan in impaired glucose tolerance outcomes research study. Circulation-Heart Failure, 6 (2), 203-+. doi: 10.1161/CIRCHEARTFAILURE.112.000086 |
|
2010 Journal Article Antiplatelet therapy in percutaneous coronary intervention: recent advances in oral antiplatelet agentsWong, Yee W., Prakash, Roshan and Chew, Derek P. (2010). Antiplatelet therapy in percutaneous coronary intervention: recent advances in oral antiplatelet agents. Current Opinion in Cardiology, 25 (4), 305-311. doi: 10.1097/HCO.0b013e328339f1aa |
|
2006 Journal Article Effect of the anti-anginal agent, perhexiline, on neutrophil, valvular and vascular superoxide formationKennedy, Jennifer A., Beck-Oldach, Konstanz, McFadden-Lewis, Kate, Murphy, Geraldine A., Wong, Yee W., Zhang, Yi and Horowitz, John D. (2006). Effect of the anti-anginal agent, perhexiline, on neutrophil, valvular and vascular superoxide formation. European Journal of Pharmacology, 531 (1-3), 13-19. doi: 10.1016/j.ejphar.2005.11.058 |
